{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:23:29Z","timestamp":1791141809277,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.ijpharm.2003.07.015","type":"journal-article","created":{"date-parts":[[2004,4,10]],"date-time":"2004-04-10T10:51:45Z","timestamp":1081594305000},"page":"91-97","source":"Crossref","is-referenced-by-count":94,"title":["Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin"],"prefix":"10.1016","volume":"277","author":[{"given":"T","family":"Mor\u00e7\u00f6l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nagappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Nerenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.D","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2003.07.015_BIB1","unstructured":"Abbas, R., Baugham, R.A., Vries, D., Dinh, S., Arbit, E., 2001. Pharmacokinetics of human insulin delivered orally in healthy volunteers, Poster presentation. Diabetes Technology Meeting, San Francisco, 2\u20133 November."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB2","unstructured":"Bell, S.J.D., Morcol, T., He, Q., 2002. Therapeutic calcium phosphate particles and method of manufacture and use. US Patent 6,355,271."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB4","doi-asserted-by":"crossref","unstructured":"Coudhari, K.B., Labhasetwar, V., Dorle, A.K., 1994. Liposomes as carrier for oral administration of insulin: Effect of formulation factors. J. Microencapsul. 11, 319\u2013325.","DOI":"10.3109\/02652049409040461"},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB5","doi-asserted-by":"crossref","unstructured":"Damage, C., Michel, C., Aprahamian, M., Couvreur, P., 1988. New approach for oral administration of insulin with polyalkyocyanoacrylate nanocapsules as drug carrier. Diabetes 37, 246\u2013251.","DOI":"10.2337\/diab.37.2.246"},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/CDLI.7.6.899-903.2000","article-title":"Calcium phospahe nanoparticle adjuvant","volume":"7","author":"He","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB7","doi-asserted-by":"crossref","unstructured":"Hosney, E.A., Ghilzai, N.M.K., Al-Najar, A., Elmazar, M.M.A., 1998. Hypoglycemic effect of oral insulin in diabetic rabbits using pH-dependent coated capsules containing sodium salicylate without and with sodium cholate. Drug Dev. Ind. Pharm. 24, 307\u2013311.","DOI":"10.3109\/03639049809085625"},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB8","doi-asserted-by":"crossref","unstructured":"Loehry, C.A., Axon, A.T.R., Hilton, P.J., Hider, R.C., Creamer, B., 1970. Permeability of the small intestine to substances at different molecular weight. Gut 11, 466\u2013470.","DOI":"10.1136\/gut.11.6.466"},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB9","doi-asserted-by":"crossref","unstructured":"Michel, C., Aprahamian, M., Defontaine, L., Couvreur, P., Damge, C., 1991. The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats. J. Pharm. Pharmacol. 43, 1\u20135.","DOI":"10.1111\/j.2042-7158.1991.tb05437.x"},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1021\/bp010023x","article-title":"Model process for removal of caseins from milk of transgenic animals","volume":"17","author":"Morcol","year":"2001","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB11","unstructured":"Modi, P., 2001. The evolving role of oral insulin in treatment of diabetes, Poster presentation. Diabetes Technology Meeting, San Francisco, 2\u20133 November."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB12","unstructured":"Morcol, T., Bell, S.J.D., 2001b. Method for processing milk. US Patent 6,183,803."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB13","unstructured":"Morcol, T., Nagappan, P., He, Q., Bell, S.J.D., 2001a. Calcium phosphate particles as pulmonary and injectable insulin delivery system in diabetic mice, Poster presentation. Diabetes Technology Meeting, San Francisco, 2\u20133 November."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB14","unstructured":"Price, C.H., 2001. Oral delivery of modified insulin. Diabetes Technology Meeting San Francisco, 2\u20133 November."},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(00)03638-2","article-title":"Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomized proof-of-concept study","volume":"357","author":"Skyler","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2003.07.015_BIB16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/03639049809082359","article-title":"Recent approaches in insulin delivery","volume":"26","author":"Trehan","year":"1998","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T23:16:26Z","timestamp":1585696586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517304001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0378517304001395"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2003.07.015","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}